TMCI - Treace Medical Concepts - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TMCI is currently covered by 5 analysts with an average price target of $4.96. This is a potential upside of $2.51 (8.3%) from yesterday's end of day stock price of $4.58.

Treace Medical Concepts's activity chart (see below) currently has 93 price targets and 84 ratings on display. The stock rating distribution of TMCI is 72.73% HOLD and 27.27% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.63% with an average time for these price targets to be met of 64.36 days.

Highest price target for TMCI is $7, Lowest price target is $3, average price target is $4.96.

Most recent stock forecast was given by RICHARD NEWITTER from TRUIST on 10-Aug-2026. First documented stock forecast 18-May-2021.

Best performing analysts who are covering TMCI - Treace Medical Concepts:

Drew Ranieri Robbie Marcus Rick Wise Richard Newitter Danielle Antalffy

Currently out of the existing stock ratings of TMCI, 8 are a HOLD (72.73%), 3 are a BUY (27.27%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 16-Jul-2024

$5

$0.49 (10.86%)

$4

1 months 5 days ago
(10-Aug-2026)

8/21 (38.1%)

$0.33 (7.07%)

97

Buy Since 31-Dec-2024

$7

$2.54 (56.95%)

$7.5

6 months 13 days ago
(02-Mar-2026)

0/3 (0%)

$5.34 (321.69%)

Hold Since 06-Nov-2024

$3

$-1.46 (-32.74%)

8 months 8 days ago
(07-Jan-2026)

6/11 (54.55%)

$0.14 (4.90%)

67

Buy Since 07-Nov-2025

$16

10 months 8 days ago
(07-Nov-2025)

1/10 (10%)

$5.49 (52.24%)

120

Hold Since 07-Aug-2024

$5.85

$1.39 (31.17%)

$6.5

10 months 8 days ago
(07-Nov-2025)

3/7 (42.86%)

$1.38 (30.87%)

46

Show more analysts

Please expand the browser size to see the chart

What is TMCI (Treace Medical Concepts) average time for price targets to be met?

On average it took 64 days for the stock forecasts to be reached, with an average price target met ratio of 36.63%.

Which analyst most recently updated their price target on TMCI (Treace Medical Concepts)?

Richard Newitter

Which analyst has the most public recommendations on TMCI (Treace Medical Concepts)?

Richard Newitter works at TRUIST and has 83 price targets and 43 ratings on TMCI

Which analyst is the currently most bullish on TMCI (Treace Medical Concepts)?

Robbie Marcus with the highest potential upside of $3.54

Which analyst is the currently most reserved on TMCI (Treace Medical Concepts)?

Rick Wise with the lowest potential downside of -$1.51

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?